产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 98% | 询价 | |||
| 5mg | 98% | 询价 | |||
| 10mg | 98% | 询价 | |||
| 25mg | 98% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 98% | 询价 | |||
| 5mg | 98% | 询价 | |||
| 10mg | 98% | 询价 | |||
| 25mg | 98% | 询价 |
CAS No. |
870677-05-7 |
|---|---|
中文名称 |
((1aR,7aS,8S,10aS,10bR,Z)-8-((二甲氨基)甲基)-1a,5-二甲基-2,3,6,7,7a,8,10a,10b-八氢-氧杂环丙烷并[2',3':9,10]环癸[1,2-b]呋喃-9(1aH)-酮) |
英文名称 |
(1AR,7aS,8S,10aS,10bR,Z)-8-((dimethylamino)methyl)-1a,5-dimethyl-2,3,6,7,7a,8,10a,10b-octahydrooxireno[2',3':9,10]cyclodeca[1,2-b]furan-9(1aH)-one |
别名 |
(S)-DMAPT | CS-0006176 | HY-16172 | DMAPT | (1S,2R,4R,7Z,11S,12S)-12-[(dimethylamino)methyl]-4,8-dimethyl-3,14-dioxatricyclo[9.3.0.0?,?]tetradec-7-en-13-one | NSC-734325 | LC-1 | (1S,2R,4R,7Z,11S,12S)-12-[(dimethylamino)methyl]-4,8-dimethyl-3,14-dioxatric |
标准英文名 |
(1aR,7aS,8S,10aS,10bR,Z)-8-((dimethylamino)methyl)-1a,5-dimethyl-2,3,6,7,7a,8,10a,10b-octahydrooxireno[2',3':9,10]cyclodeca[1,2-b]furan-9(1aH)-one |
分子式 |
C17H27NO3 |
分子量 |
293.41 |
精确分子量 |
293.20 |
SMILES |
C[C@@]12CC/C=C(C)\CC[C@]3([C@@H](CN(C)C)C(O[C@@]3([C@]1(O2)[H])[H])=O)[H] |
标准SMILES |
CC1CC[C@@H]2[C@H](OC(=O)[C@@H]2CN(C)C)[C@H]2O[C@]2(C)CCC=1 |
用途 |
Oral NF-κB inhibitor with potential antitumor and antimetastatic activities; exhibits cytotoxicity against primary acute myeloid leukemia cells (LD50 = 1.7 μM). |
InChIKey |
UJNSFDHVIBGEJZ-CMRIBGNTSA-N |
|
|
评论 |
|---|